Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study
- PMID: 35141330
- PMCID: PMC8818421
- DOI: 10.1155/2022/1565207
Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study
Abstract
Background: The dismal prognosis of gastric signet ring cell carcinoma (GSRC) is a global problem. The current study is conducted to comprehensively evaluate clinicopathological features and survival outcomes in GSRC patients stratified by anatomic subsites. Then, predictive nomograms are constructed and validated to improve the effectiveness of personalized management.
Method: The patients diagnosed with GSRC were recruited from the online SEER database. The influence of anatomic subsites on overall survival (OS) and cancer-specific survival (CSS) was evaluated using multivariate Cox regression and Kaplan-Meier analysis. Then, we employed propensity score matching (PSM) technique to decrease selection bias and balance patients' epidemiological factors. Predictive nomograms were constructed and validated. Sensitivity analysis was performed to validate the conclusion.
Results: Multivariate Cox regression demonstrated that the patients with overlapping gastric cancer (OGC) suffered the highest mortality risk for OS (HR, 1.29; 95% CI, 1.23-1.36; P < 0.001) and CSS (HR, 1.33; 95% CI, 1.28-1.37; P < 0.001). Age, TNM stage, tumor localization, tumor size, surgery, and chemotherapy presented a highly significant relationship with OS and CSS. Following subgroup and PSM analysis, OGC patients were confirmed to have the worst OS and CSS. Then, nomograms predicting 6-month, 12-month, and 36-month survival were constructed. The area under the curve (AUC) value in ROC was 0.775 (95% CI, 0.761-0.793) for 6-month survival, 0.789 (95% CI, 0.776-0.801) for 12-month survival, and 0.780 (95% CI, 0.765-0.793) for 36-month survival in the OS group, while in the CSS group, it was 0.771 (95% CI, 0.758-0.790) for 6-month survival, 0.781 (95% CI, 0.770-0.799) for 12-month survival, and 0.773 (95% CI, 0.762-0.790) for 36-month survival.
Conclusion: We identified anatomic subsites as a predictor of survival in those with GSRC. Patients with OGC suffered the highest mortality risk. The proposed nomograms allowed a relatively accurate survival prediction for GSRC patients.
Copyright © 2022 Yangyang Xie et al.
Conflict of interest statement
The authors have no conflict of interests with any organizations or individuals.
Figures
Similar articles
-
A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027912. doi: 10.1177/15330338211027912. Technol Cancer Res Treat. 2021. PMID: 34190015 Free PMC article.
-
Development and validation of a tumor size-stratified prognostic nomogram for patients with gastric signet ring cell carcinoma.Updates Surg. 2024 Dec;76(8):2813-2824. doi: 10.1007/s13304-024-02020-0. Epub 2024 Nov 4. Updates Surg. 2024. PMID: 39495439 Free PMC article.
-
Development and validation of nomograms based on the SEER database for the risk factors and prognosis of distant metastasis in gastric signet ring cell carcinoma.Medicine (Baltimore). 2024 Nov 1;103(44):e40382. doi: 10.1097/MD.0000000000040382. Medicine (Baltimore). 2024. PMID: 39496020 Free PMC article.
-
Update on diagnosis and treatment of early signet-ring cell gastric carcinoma: A literature review.World J Gastrointest Endosc. 2023 Apr 16;15(4):240-247. doi: 10.4253/wjge.v15.i4.240. World J Gastrointest Endosc. 2023. PMID: 37138936 Free PMC article. Review.
-
Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges.Cancer Manag Res. 2020 Sep 3;12:7973-7981. doi: 10.2147/CMAR.S268032. eCollection 2020. Cancer Manag Res. 2020. PMID: 32943931 Free PMC article. Review.
Cited by
-
Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer.Clin Transl Oncol. 2024 Mar;26(3):756-764. doi: 10.1007/s12094-023-03305-3. Epub 2023 Aug 22. Clin Transl Oncol. 2024. PMID: 37606846
-
Pathological Nodal Staging Score for Gastric Signet Ring Cell Carcinoma: A Clinical Tool of Adequate Nodal Staging.Diagnostics (Basel). 2022 Sep 22;12(10):2289. doi: 10.3390/diagnostics12102289. Diagnostics (Basel). 2022. PMID: 36291978 Free PMC article.
-
Construction and validation of a prognostic model for gastric cancer patients with tumor deposits.PeerJ. 2024 Jul 10;12:e17751. doi: 10.7717/peerj.17751. eCollection 2024. PeerJ. 2024. PMID: 39006037 Free PMC article.
-
Who are optimal candidates for primary tumor resection in patients with metastatic gastric adenocarcinoma? A population-based study.PLoS One. 2024 Jan 24;19(1):e0292895. doi: 10.1371/journal.pone.0292895. eCollection 2024. PLoS One. 2024. PMID: 38266030 Free PMC article.
-
Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features.Nat Commun. 2023 May 24;14(1):2985. doi: 10.1038/s41467-023-38426-4. Nat Commun. 2023. PMID: 37225691 Free PMC article.
References
-
- Henson D., Dittus C., Younes M., Nguyen H., Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Archives of Pathology & Laboratory Medicine . 2004;128(7):765–770. doi: 10.5858/2004-128-765-DTITIA. - DOI - PubMed
-
- Wu H., Rusiecki J., Zhu K., Potter J., Devesa S. S. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology . 2009;18(7):1945–1952. doi: 10.1158/1055-9965.EPI-09-0250. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous